Title : Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial.

Pub. Date : 2007 Dec 3

PMID : 18053191






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: COX-2 inhibitors, such as celecoxib, and ubiquitin-proteasome pathway inhibitors, such as bortezomib, can down-regulate NF-kappaB, a transcription factor implicated in tumor growth. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens